Home - Products - Microbiology/Virology - HCV - 7-benzyl-5,6-dimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine

7-benzyl-5,6-dimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine

CAS No. 56344-53-7

7-benzyl-5,6-dimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine( —— )

Catalog No. M28393 CAS No. 56344-53-7

Oxytetracycline (OTC) is a broad-spectrum antibiotic that acts by inhibiting protein synthesis in D2401bacteria.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 31 In Stock
25MG 54 In Stock
50MG 77 In Stock
100MG 116 In Stock
200MG 178 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    7-benzyl-5,6-dimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
  • Note
    Research use only, not for human use.
  • Brief Description
    Oxytetracycline (OTC) is a broad-spectrum antibiotic that acts by inhibiting protein synthesis in D2401bacteria.
  • Description
    Oxytetracycline (OTC) is a broad-spectrum antibiotic that acts by inhibiting protein synthesis in D2401bacteria. Oxytetracycline prevents the binding from aminoacil-tRNA to the complex m-ribosomal RNA. Oxytetracycline also possesses anti-HSV-1 activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Microbiology/Virology
  • Target
    HCV
  • Recptor
    S1P|Apoptosis
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    56344-53-7
  • Formula Weight
    252.321
  • Molecular Formula
    C15H16N4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cc1c(C)c2c(N)ncnc2n1Cc1ccccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Draper JM, et al. Discovery and evaluation of inhibitors of human ceramidase. Mol Cancer Ther. 2011 Nov;10(11):2052-61.
molnova catalog
related products
  • Nucleoside-Analog-1

    A 4′-azidocytidine analogue that shows anti-HCV activity.

  • VCH-916 free acid(12...

    VCH-916 is a novel nonnucleoside HCV NS5B polymerase inhibitor.

  • Faldaprevir

    A potent, selective noncovalent competitive inhibitor of HCV NS3/4A protease with Ki of 2.6 and 2.0 nM for GT1a and 1b NS3-NS4A protease, respectively.